Posts by: Ana Pena, PhD

Ana Pena, PhD

Ana is a molecular biologist with a passion for communication and discovery. As a science writer, her goal is to provide readers, in particular patients and healthcare providers, with clear and quality information about the latest medical advances. Ana holds a Ph.D. in Biomedical Sciences from the University of Lisbon, Portugal, where she specialized in infectious diseases, epigenetics, and gene expression.

March 5, 2020March 5, 2020

Sulforaphane Plant Compound Eases Pain, Inflammation in Rat Model

News

Sulforaphane, a natural compound found in broccoli and other vegetables, alleviates pain, lessens inflammation, and reduces lesion growth in a rat model of sciatic endometriosis, an early study has found. ... Read more

January 9, 2020January 9, 2020

Trial Recruiting Women to Test Vaginal Rings of Quinagolide for Endometriosis Pain

News

A Phase 2 clinical trial is recruiting adult women with endometriosis to evaluate the safety and effectiveness of an insertable vaginal ring of quinagolide to treat moderate to severe endometriosis ... Read more

November 19, 2019November 19, 2019

Orilissa Lowers Ovulation Rates But Does Not Seem to Affect Ovaries’ Egg Supply, Phase 1 Trial Shows

News

Orilissa (elagolix), an FDA-approved medication for managing endometriosis pain, lowers ovulation rates in a dose-dependent manner but does not seem to affect the amount of developing eggs in the ovaries ... Read more

November 12, 2019November 12, 2019

Egg Counts, Quality Lower in Women with Ovarian Cysts and Infertility, Study Finds

News

Ovarian cysts negatively affect the quantity and quality of eggs produced by women with endometriosis-associated infertility, which may affect the outcomes of assisted reproduction, a study reports. The quality of ... Read more

October 4, 2019October 4, 2019

New Model Predicts Likelihood of Giving Birth After Surgery and ART

News

A new tool appears to be more accurate than commonly used indexes for predicting the likelihood of successfully giving birth for women with endometriosis who undergo surgery followed by assisted ... Read more

September 10, 2019September 10, 2019

Early Trial Data Support Nolasiban as Aiding Pregnancy in Women Using In Vitro Fertilization, ObsEva Says

News

Results of small clinical study support the potential of oral nolasiban to improve pregnancy and live-birth rates among women undergoing embryo transfer following in vitro fertilization (IVF), ObsEva announced. These findings can be ... Read more

September 3, 2019September 3, 2019

1 in 9 Women in Australia Diagnosed with Endometriosis by Mid-40s, Report Finds

News

About 1 in every 9 women in Australia are diagnosed with endometriosis by their 40s, according to a report by the Australian Institute of Health and Welfare. More than 34,000 ... Read more

August 23, 2019August 23, 2019

One of Two Pivotal Trials into Relugolix’s Ability to Safely Treat Pain of Endometriosis Fully Enrolled, Myovant Says

News

SPIRIT 2, one of two pivotal Phase 3 clinical trials evaluating once daily relugolix pills combined with estradiol and progestin in treating pain in women with endometriosis, is now fully enrolled, its developer Myovant ... Read more

May 17, 2019May 17, 2019

ObsEva Launches Two Key Phase 3 Trials to Confirm Efficacy of Linzagolix

News

ObsEva announced the initiation of two key Phase 3 trials to confirm the safety and efficacy of its therapy linzagolix for endometriosis-associated pelvic pain and to support the therapy’s approval ... Read more

April 16, 2019April 16, 2019

Symptoms Often Subtle in Diaphragm Rupture Caused by Endometriosis, Case Report Shows

News

Diaphragmatic endometriosis is rare but may lead to a rupture of the diaphragm, the muscle essential for breathing, without any or very subtle symptoms, a case report and literature review details. The report, “Non-traumatic ... Read more